Skip to main content

COVID-19 Topic Center

Non-Radiographic Axial Spondyloarthritis News

News
Some 45.5% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) deemed at moderate risk of cardiovascular disease per the Systematic COronary Risk Evaluation (SCORE) model were reclassified as very high risk after ultrasound imaging revealed carotid plaques, according to a study…
News
Although patients with ankylosing spondylitis (AS) and patients with non-radiographic axial spondyloarthritis (nr-axSpA) share many of the same symptoms and a similar burden of disease, those with nr-axSpA are less likely to be prescribed a biologic in the United States. Researchers published their…
News
Patients with axial spondyloarthritis who experienced higher levels of perceived stress and anxiety during the current shelter-in-place orders had significantly higher disease activity levels compared with patients with less stress and anxiety, according to a study published online in ACR Open…
News
Infliximab added to naproxen led to higher rates of partial remission among patients with spondyloarthropathies, according to a study in the online Rheumatology. Patients with ankylosing spondylitis who received infliximab in addition to naproxen had double the rate of partial remission than…
Back to Top